These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 1661329
21. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells. Swingler S, Easton A, Morris A. AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755 [Abstract] [Full Text] [Related]
22. Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression. Bernstein MS, Tong-Starksen SE, Locksley RM. J Clin Invest; 1991 Aug; 88(2):540-5. PubMed ID: 1907615 [Abstract] [Full Text] [Related]
23. Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. Barry PA, Pratt-Lowe E, Peterlin BM, Luciw PA. J Virol; 1990 Jun; 64(6):2932-40. PubMed ID: 2159554 [Abstract] [Full Text] [Related]
24. Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation. Shattock RJ, Friedland JS, Griffin GE. J Virol; 1993 Jun; 67(6):3569-75. PubMed ID: 7684470 [Abstract] [Full Text] [Related]
25. Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus. Biegalke BJ, Geballe AP. Virology; 1991 Jul; 183(1):381-5. PubMed ID: 1647074 [Abstract] [Full Text] [Related]
26. Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by cis-platin. Spandidos DA, Zoumpourlis V, Kotsinas A, Maurer HR, Patsilinacos P. Genet Anal Tech Appl; 1990 Sep; 7(5):138-41. PubMed ID: 1965411 [Abstract] [Full Text] [Related]
27. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Davis MG, Kenney SC, Kamine J, Pagano JS, Huang ES. Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8642-6. PubMed ID: 2825201 [Abstract] [Full Text] [Related]
28. Human retinal and brain cell lines: A model of HCMV retinitis and encephalitis. Dutt K, Ezeonu I. DNA Cell Biol; 2006 Oct; 25(10):581-96. PubMed ID: 17132089 [Abstract] [Full Text] [Related]
29. Estradiol negatively regulates HIV-LTR promoter activity in glial cells. Wilson ME, Allred KF, Bisotti AJ, Bruce-Keller A, Chuahan A, Nath A. AIDS Res Hum Retroviruses; 2006 Apr; 22(4):350-6. PubMed ID: 16623639 [Abstract] [Full Text] [Related]
30. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function. Cho S, Kindt TJ, Zhao TM, Sawasdikosol S, Hague BF. AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293 [Abstract] [Full Text] [Related]
31. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element. Roebuck KA, Rabbi MF, Kagnoff MF. AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359 [Abstract] [Full Text] [Related]
32. Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus. Stellrecht KA, Sperber K, Pogo BG. J Virol; 1992 Apr; 66(4):2051-6. PubMed ID: 1548751 [Abstract] [Full Text] [Related]
33. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B. Negrini M, Rimessi P, Sabbioni S, Caputo A, Balboni PG, Gualandri R, Manservigi R, Grossi MP, Barbanti-Brodano G. Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615 [Abstract] [Full Text] [Related]
34. Retinoblastoma gene inhibits transactivation of HIV-LTR linked gene expression upon co-transfection in He La cells. Prasad MV, Shanmugam G. Biochem Mol Biol Int; 1993 Jan; 29(1):57-62. PubMed ID: 8490568 [Abstract] [Full Text] [Related]
35. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B. J Biomed Sci; 1998 Jan; 5(1):31-44. PubMed ID: 9570512 [Abstract] [Full Text] [Related]
36. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat. Sawaya BE, Khalili K, Amini S. J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608 [Abstract] [Full Text] [Related]
37. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies. Mukhtar M, Duan L, Bagasra O, Pomerantz RJ. Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098 [Abstract] [Full Text] [Related]
38. The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5' long terminal repeat. Lin JC. Biochem Biophys Res Commun; 1993 Aug 31; 195(1):242-9. PubMed ID: 8395825 [Abstract] [Full Text] [Related]
39. Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression. Germinario RJ, Colby-Germinario SP, Acel A, Chandok R, Davison K, Mak J, Kleiman L, Faust E, Wainberg MA. AIDS Res Hum Retroviruses; 1999 Jun 10; 15(9):829-36. PubMed ID: 10381171 [Abstract] [Full Text] [Related]
40. HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines. Russo FO, Patel PC, Ventura AM, Pereira CA. Virus Res; 1999 Oct 10; 64(1):87-94. PubMed ID: 10500286 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]